Efficacy and Durability of Exenatide in Combination with Pioglitazone vs. Basal-Bolus Insulin in Poorly Controlled Type 2 Diabetic Patients: The QATAR Study

被引：0
|
作者：
Abdul-Ghani, Muhammad
Mujahed, Osama
Mujahed, Ayman
Hassoun, Shai-Maa
Alkasem, Meis
Abou Samra, Abdel Badi
Zirie, Mahmoud
Defronzo, Ralph A.
Jayyousi, Amin
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
188-OR
引用
收藏
页码：A49 / A49
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of insulin degludec/liraglutide (IDegLira) vs basal-bolus therapy in patients with type 2 diabetes: DUAL VII trial
    Billings, L. K.
    Doshi, A.
    Gouet, D.
    Oviedo, A.
    Rodbard, H. W.
    Tentolouris, N.
    Gron, R.
    Halladin, N.
    Jodar, E.
    DIABETOLOGIA, 2017, 60 : S366 - S366
  • [22] Efficacy of switching from basal-bolus insulin therapy to twice-daily insulin degludec/insulin aspart co-formulation plus insulin aspart in patients with poorly controlled type 2 diabetes
    Gunes, E.
    Gunes, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (14) : 6691 - 6699
  • [23] Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes
    Raskin, Philip
    Gylvin, Titus
    Weng, Wayne
    Chaykin, Louis
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2009, 25 (06) : 542 - 548
  • [24] Distinct pharmacodynamics of insulin glargine and insulin detemir: Crossover comparison in Type 1 and Type 2 diabetic patients on basal-bolus regimen
    Kato, Tomoko
    Tokubuchi, Ichiro
    Muraishi, Kazuhisa
    Sato, Shuichi
    Kato, Tamotsu
    Hara, Kento
    Tanaka, Kayo
    Kaku, Hiroo
    Tajiri, Yuji
    Yamada, Kentaro
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (03) : E64 - E66
  • [25] Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) vs. Basal-Bolus (BB) Therapy in Patients with Type 2 Diabetes (T2D): DUAL VII Trial
    Billings, Liana K.
    Doshi, Ankur
    Gouet, Didier
    Oviedo, Alejandra
    Rodbard, Helena W.
    Tentolouris, Nikolaos
    Gron, Randi
    Halladin, Natalie
    Jodar, Esteban
    DIABETES, 2017, 66 : A36 - A36
  • [26] Efficacy and feasibility of basal-bolus insulin regimens and a discharge-strategy in hospitalised patients with type 2 diabetes - the HOSMIDIA study
    Perez, A.
    Reales, P.
    Barahona, M. J.
    Romero, M. G.
    Minambres, I.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (10) : 1264 - 1271
  • [27] Assessment of treatment satisfaction in long-acting insulin analogues: Evidence from a basal-bolus regimen treating type 1 diabetic patients with insulin detemir vs. insulin glargine
    Brod, Meryl
    Lammert, Morten
    DIABETES, 2006, 55 : A558 - A558
  • [28] Intensification of Basal Insulin Therapy With Step-Wise Addition of Insulin Aspart Boluses vs. Basal-Bolus Therapy: The FullSTEP™ Study
    Rodbard, Helena W.
    Visco, Virginia E.
    Shu, David H. W.
    Andersen, Henning
    Hiort, Line C.
    Gross, Jorge L.
    DIABETES, 2013, 62 : A66 - A66
  • [29] Diabetes-related outcomes with basal-bolus vs. premixed insulin among veterans with type 2 diabetes: A single institutional retrospective study
    Bai, Ravisha
    Batra, Kavita
    Yap, Charmaine
    Izuora, Kenneth
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 366 (01): : 38 - 43
  • [30] Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
    Bellido, Virginia
    Suarez, Lorena
    Galiana Rodriguez, Maria
    Sanchez, Cecilia
    Dieguez, Marta
    Riestra, Maria
    Casal, Florentino
    Delgado, Elias
    Menendez, Edelmiro
    Umpierrez, Guillermo E.
    DIABETES CARE, 2015, 38 (12) : 2211 - 2216
12345